1.888.321.7828 sales@pepid.com

Timely Insights for Healthcare Experts 

FDA approved Aemcolo (rifamycin) for Travelers’ Diarrhea.

The FDA approved Aemcolo (rifamycin) yesterday for the treatment of travelers’ diarrhea. Aemcolo is an antibacterial drug to treat noninvasive strains of Escherichia coli (E. coli) not complicated by fever or blood in the stool. The FDA estimates 10-40% of travelers...

read more
FDA Approves a New Version of OTC Inhaler Primatene Mist

FDA approves a new version of Primatene Mist, the only OTC metered-dose inhaler. Primatene Mist is approved by the FDA as an OTC drug to provide temporary relief for symptoms of mild, intermittent asthma. Primatene Mist is only approved for those who have been...

read more
ACE Inhibitors Linked to Lung Cancer

A cohort study by the United Kingdom Clinical Research Datalink associated the use of ACEIs with an increased risk of lung cancer. The association elevated among people using ACE Inhibitors for more than five years. The study consisted of 992,061 patients treated with...

read more
Another Rise in Acute Flaccid Myelitis (AFM) in Kids

The CDC is baffled by the cause of polio-like disease, Acute Flaccid Myelitis (AFM), affecting children in the United States. A reoccurring outbreak of AFM has been affecting Americans 21 and under since 2014. The CDC has recorded spikes in cases of Acute Flaccid...

read more
Red Tide Spreading Across Florida Coastline

Toxic dinoflagellates algal blooms known as “red tides” are spreading across the Florida coastline, killing thousands of marine animals, and causing respiratory and gastrointestinal distress in residents. People in effected areas are warned not to swim in the water,...

read more
The FDA approved cemiplimab-rwlc (Libtayo)

The FDA approved cemiplimab-rwlc (Libtayo) for treatment of locally advanced, or metastatic, cutaneous squamous cell carcinoma (CSCC). This is the first drug treatment approved for advanced CSCC, the second most common cancer in the U.S. Please see the FDA website for...

read more
FDA Approves First Generic EpiPen (epinephrine)

The FDA has approved the first generic version of Mylan’s EpiPEN and EpiPen Jr (epinephrine) auto injector used to treat emergency allergic reactions, such as the life-threatening anaphylaxis. The generic epinephrine auto-injector has been green flagged to market in...

read more
First FDA Approved Targeted RNA-based Therapy

The U.S. FDA approved the first of its kind targeted RNA-based therapy Onpattro (patisiran) to treat peripheral nerve disease (polyneuropathy) caused from hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients. This is the first FDA approved treatment...

read more
First FDA approved Drug Treatment for Smallpox

Tecovirimat (TPOXX) is the first FDA approved drug treatment of smallpox. In 1980, WHO declared that smallpox was eradicated; however, tecovirimat was developed as a counter to the possible use of smallpox as a bio-weapon. It is the first product awarded a Material...

read more
The Mosquito-Borne Keystone Virus First Known Human Infection

Another mosquito-borne virus has been confirmed to infect humans, after a report published in June from the peer-reviewed medical journal Clinical Infectious Diseases. Keystone has been known to infect animals since its discovery in Tampa-Bay area in 1964 but has...

read more
Intravenous Ketamine for Chronic Pain Consensus Guidelines

The American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists' Committees on Pain Medicine and Standards and Practice Parameter have determined a consensus guideline for the use of...

read more